70+
Study Sites
Headquartered at Fred Hutch in Seattle, the Network includes over 70 sites on four continents staffed by teams with expertise in vaccinology, immunology, and in conducting clinical trials.
100+
Clinical Trials
For more than 20 years, the HVTN has conducted all phases of clinical trials based on the latest developments in vaccinology and immunology for the prevention of HIV, tuberculosis and COVID-19.
95+
Scholar Awards
We are investing in the next generation of HIV prevention researchers with grants and mentoring for African American/Black, Hispanic/Latinx, Native American/American Indian/Alaska Native, Native Hawaiian, Asian and Pacific Islander medical students.
HVTN Mission
Our mission is to fully characterize the safety, immunogenicity, and efficacy of HIV vaccine candidates with the goal of developing a safe, effective vaccine as rapidly as possible for prevention of HIV globally.
Who We Are
We are the world’s largest publicly-funded international collaboration focused on the evaluation of vaccines to prevent HIV/AIDS.
What We Do
Our sites conduct all phases of clinical trials — from evaluating early phase vaccines for safety and immunogenicity to testing vaccine efficacy.
Get Involved
Worldwide, thousands of people have participated in HIV vaccine trials. Volunteers are the heroes of vaccine development.
It Takes a Village
The HIV Vaccine Trials Network is an international partnership of research scientists, clinical trial sites, laboratories, statisticians, regulators and ethicists, participants, volunteers and community representatives working with industry, academia, and governments in the global search for a preventive HIV vaccine.
Recent HVTN News & Announcements
Cape Town HVTN Immunology Laboratory (CHIL) Turns 10
The HVTN celebrated the 10th anniversary of the Cape Town HVTN Immunology Laboratory (CHIL) during the Regional Meeting on November 5, 2024.
Meet the 2024 Scientific Leadership Development (SLD) Awardees
The 3rd cohort of SLD awardees has been selected for a year-long mentored project starting in 2024. Please join the HVTN in congratulating these emerging leaders.
Read the Latest Community Compass Issue
This issue of Community Compass serves as a celebration of the legacy and life of Dr. Wallace. While his presence is missed, his work continues.
